Wan Nabilatul Huda Wan Ghazali1*, Jeyanthi Suppiah1, Nor Aziyah Mat Rahim1, Nur Ain Zahidah Zainudin1, Alia Nabila Abdul Halim1, Intan Surianne Mat Sahat1, Siti Mukhaiyarah Mahtar1, Rozainanee Mohd Zain1
1. Virology Unit, Infectious Disease Research Centre (IDRC), Institute for Medical Research (IMR), National Institute of Health (NIH), Ministry of Health Malaysia, 40170 Shah Alam, Selangor, Malaysia
*Corresponding author: Wan Nabilatul Huda W. G..
ABSTRACT
INTRODUCTION: Echovirus 11 (E-11) poses a life-threatening risk to children, especially neonates, as evidenced by recent severe E-11 outbreaks globally, including those affecting Malaysia. This highlights the need for a thorough understanding of the disease's demographic and laboratory characteristics to enhance diagnostic accuracy and patient management.
OBJECTIVE(S): This study aimed to delineate the demographic and laboratory profile of E-11 infections associated with recent E-11 outbreaks among young children in Malaysia.
MATERIALS & METHODS: The clinical samples of E-11 suspected patients during the outbreaks between November 2023 and January 2024 were sent by hospital laboratories in Malaysia to the Institute for Medical Research (IMR). The samples were subjected to an in-house E-11 real-time RT-PCR. The demographic and laboratory data of the cases were retrospectively analysed.
RESULTS: E-11 infection was laboratory-confirmed in 17.9% (40/223) of the suspected cases. Among these 40 cases, the majority (57.5%) were neonates less than one month old, followed by infants aged ≥1-2 months (25%), >2-6 months (15%), and >6 months-1 year (2.5%). No cases were observed in children aged ≥1 year. The highest prevalence was reported in the Federal Territory of Putrajaya (14/40, 35%), Penang (9/40, 22.5%), and Selangor (9/40, 22.5%). The remaining cases were from Melaka, Kuala Lumpur, and Johor. The majority of E-11 confirmed cases (65.0%, 26/40) required PICU/NICU admission. Furthermore, 11 (27.5%) cases involved premature delivery, 16 (40%) were full-term births, while the prematurity status of the remaining 13 cases (32.5%) remained unknown. The E-11 detection rate showed a statistically significant difference by sample type (χ2(3) = 9.609, p = 0.022), with the highest detection in rectal swab/stool samples (71.7%), followed by throat swabs (17.0%), and the lowest in serum/CSF (5.7%).
CONCLUSION: Findings collectively emphasise the vulnerability of neonates to severe E-11 disease and stress the importance of targeted surveillance with appropriate diagnostic sampling for effective outbreak management and clinical care.
KEYWORDS: Echovirus 11, Neonates, Enterovirus, Outbreak


